Evidence Synthesis
NexuSurgL's 72.21% gross margin accelerated to, up from 9.61%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 4 Sept 2026, 13:17
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
NexuSurgL's 72.21% gross margin accelerated to, up from 9.61%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 72.21 % | 9.61 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 9.61 % | 9.06 | ▲ |
| REVENUE_GROWTH_YOY | 47.7 % | 32.1 | ▲ |
| PRICE_CHANGE_PERCENT | -7.242 % | — | - |
| DAILY_VOLUME | 24,015 shares | 3,904 | ▲ |
| CLOSE_PRICE | 26 INR | 28.03 | ▼ |